Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint.
GlobalData on MSN
Mirum concludes Phase III EXPAND trial enrolment for Livmarli
The double-blind, randomised, placebo-controlled trial will assess the efficacy and safety of Livmarli in both children and ...
Medical Device Network on MSN
Providence Medical enrols first patients in CORUS-LX system trial
Subjects are randomised to receive posterior fusion using either the CORUS-LX system or the standard posterior fusion method.
Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma. ONITT: A phase I study of nanoliposomal irinotecan with talazoparib ...
Stockhead on MSN
Cynata hits century mark in phase II aGvHD trial
100-day primary evaluation period for all 65 participants in Cynata Therapeutics phase II trial of CYP-001 in aGvHD complete The ... Read More The post Cynata hits century mark in phase II aGvHD trial ...
US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...
Impact of Lean Body Mass–Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial The trials were conducted ...
Introduction Infectious diarrhoea causes millions of deaths annually in low-income countries. Prevention strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results